Cart
sales@molnova.com
AC-262536
CAS No. 870888-46-3
AC-262536( AC 262536 | AC262536 )
Catalog No. M27843 CAS No. 870888-46-3
AC-262536 is a selective androgen receptor (SAR) modulator and exhibits potent agonist activity at the androgen receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 35 | Get Quote |
|
| 5MG | 58 | Get Quote |
|
| 10MG | 102 | Get Quote |
|
| 25MG | 222 | Get Quote |
|
| 50MG | 380 | Get Quote |
|
| 100MG | 565 | Get Quote |
|
| 500MG | 1215 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAC-262536
-
NoteResearch use only, not for human use.
-
Brief DescriptionAC-262536 is a selective androgen receptor (SAR) modulator and exhibits potent agonist activity at the androgen receptor.
-
DescriptionAC-262536 is a selective androgen receptor (SAR) modulator and exhibits potent agonist activity at the androgen receptor. It has partial agonist activity with respect to testosterone and suppresses luteinizing hormone.(In Vitro):AC-262536 inhibits dihydroxytestosterone (DHT)-induced proliferation of LNCaP in a dose-dependent manner. The effects are significant with 100 nM, and reaches a plateau with 1 μM.(In Vivo):In male sprague-dawley rats, administration of AC-262536 (subcutaneous injection, once daily for 14 consecutive days) significantly decreased LH levels by about 40% at the 3 mg/kg dose. At the 10 and 30 mg/kg doses, the effects of AC-262536 were significantly stronger than Testosterone Propionate (TP) : 1.91±0.32 ng/mL and 1.53±0.34 ng/mL vs. 3.12±0.69 ng/mL, respectively.
-
In VitroAC-262536 dose-dependently inhibits dihydroxytestosterone (DHT)-induced proliferation of LNCaP. The effects are significant with 100 nM AC-262536 (%inhibition 47.2±12.2), and reaches a plateau with 1 μM treatment (%inhibition 50.7±7.6). Thus, AC-262536 can act as a functional antagonist in prostate cells.
-
In VivoAC-262536 (3, 10, 30 mg/kg) reverses the luteinizing hormone (LH) spike in castrated rats. Animal Model:Male Sprague-Dawley rats (200-225 g)Dosage:3, 10 and 30 mg/kg Administration:Administered subcutaneously; once daily for 14 consecutive days Result:Significantly decreased LH levels by about 40% at the 3 mg/kg dose.The ED50 was determined to be 2.8 mg/kg.At the 10 and 30 mg/kg doses, the effects of AC-262536 were significantly stronger than Testosterone Propionate (TP) : 1.91±0.32 ng/mL and 1.53±0.34 ng/mL vs. 3.12±0.69 ng/mL, respectively.
-
SynonymsAC 262536 | AC262536
-
PathwayEndocrinology/Hormones
-
TargetAndrogen Receptor (AR)
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number870888-46-3
-
Formula Weight278.355
-
Molecular FormulaC18H18N2O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (179.63 mM)
-
SMILESOC1C[C@@H]2CC[C@H](C1)N2c1ccc(C#N)c2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.El-Sayed, May A.; Al-Gendy, Amal. A.; Hamdan, Dalia. I.; El-Shazly, Assem M. Phytoconstituents, LC-?ESI-?MS profile, antioxidant and antimicrobial activities of Citrus x limon L. Burm. f. Cultivar variegated pink lemon. Journal of Pharmaceutical Sciences and Research (2017), 9(4), 375-391.
molnova catalog
related products
-
Metribolone
An orally active anabolic-androgenic steroid and a 19-nortestosterone derivative that has been widely used in scientific research as a hot ligand in androgen receptor (AR) ligand binding assays (LBAs) and as a photoaffinity label for the AR.
-
ODM-201
A potent wt/mutant androgen receptor (AR) inhibitor with Ki of 11 nM.
-
Zanoterone
Zanoterone is an AR antagonist (androgen receptor).Zanoterone has antitumor activity for the treatment of genitourinary disorders and oncological disorders and may be used in the study of prostate cancer.
